Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

79
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
79
Brainstem01:19

Brainstem

3.7K
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
3.7K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

887
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
887
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

469
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
469
Neural Regulation01:37

Neural Regulation

40.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.6K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.0K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.0K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Cortical GABAergic dysfunction underlying abnormal hand movements in ARX mutation.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2019
Same author

Gelastic Cataplexy in Niemann Pick Type C.

Movement disorders clinical practice·2019
Same author

The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson's Disease.

Molecular neurobiology·2019
Same author

Tongue Protrusion Dystonia in Pantothenate Kinase-Associated Neurodegeneration.

Pediatric neurology·2019
Same author

Amantadine for Gait Dysfunction in Pantothenate Kinase-Associated Neurodegeneration.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2019
Same author

Deep brain stimulation in status dystonicus caused by anti-NMDA receptor encephalitis.

Parkinsonism & related disorders·2019

関連する実験動画

Updated: Oct 22, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.8K

パーキンソン病 パーキンソン病

Lorraine V Kalia1, Anthony E Lang1

  • 1Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada.

Lancet (London, England)
|April 24, 2015
PubMed
まとめ

パーキンソン病 (PD) は,複雑な運動および非運動症状,病理,および原因が不明である. 現在の治療法では症状が治るが,神経変性障害を遅らせないため,重大な臨床的課題が浮き彫りにされている.

科学分野:

  • 神経学 神経学とは
  • 神経科学は神経科学である.
  • 病理学 パトロジー

背景:

  • パーキンソン病 (PD) は,伝統的に,運動症状,ルイの体,および黒い質量神経細胞の喪失によって定義されています.
  • 最近の理解は,PDの異質性を明らかにし,重要な非運動的特徴と,ルイ体の範囲を超えた広範な病理を網羅しています.
  • PDの病因は多因性であり,細胞プロセスに影響を与える遺伝的および環境的要因の複雑な相互作用を伴う.

研究 の 目的:

  • パーキンソン病の複雑性の進化を見直すため.
  • パーキンソン病の診断と管理に関連する臨床的課題について議論する.
  • パーキンソン病の現在の治療アプローチの限界を強調する.

主な方法:

  • パーキンソン病に関する文献レビュー.
  • PDの症状と病理学の現在の理解の分析.
  • パーキンソン病における診断および治療上の課題の検討.

主要な成果:

  • パーキンソン病は,異質な運動および非運動症状を呈する.
  • 病理は substantia nigraを超えて広がり,複数の神経伝達物質とタンパク質集積を含む.

さらに関連する動画

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.0K
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

18.4K

関連する実験動画

Last Updated: Oct 22, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.8K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.0K
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

18.4K
  • 早期診断と効果的な症状管理は,疾患を修正する治療法がないため,依然として困難です.
  • 結論:

    • パーキンソン病は,多面的な病理学と症状を持つ複雑な神経疾患です.
    • 早期診断,症状管理,神経保護療法の欠如などに重大な臨床的課題があります.
    • PDの複雑さを解明し,効果的な治療法を開発するためにさらなる研究が必要です.